Iodiconazole cream - Anhui Jiren Pharmaceutical
Latest Information Update: 25 Nov 2015
At a glance
- Originator Second Military Medical University
- Developer Anhui Jiren Pharmaceutical
- Class Fluorobenzenes; Iodobenzenes; Propanols; Triazoles
- Mechanism of Action 14-alpha demethylase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Clinical Phase Unknown Dermatomycoses
Most Recent Events
- 25 Nov 2015 Clinical trials in Dermatomycoses in China (Topical)